Source and homeostatic functions of anti-adduct IgM in humans
人类抗加合物 IgM 的来源和稳态功能
基本信息
- 批准号:10680950
- 负责人:
- 金额:$ 24.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-22 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAge MonthsAntigensApoptoticAreaAutoimmune DiseasesAutoimmune ThrombocytopeniasB-LymphocytesB-cell receptor repertoire sequencingBindingBiological AssayBiological ProcessBone MarrowCell membraneCell secretionCell surfaceCellsCharacteristicsChemicalsClone CellsCollectionComplementComplexEpitopesExposure toFlow CytometryGut associated lymphoid tissueHousekeepingHumanHumoral ImmunitiesHypersensitivityImmunityImmunoglobulin GImmunoglobulin IsotypesImmunoglobulin MIncidenceIndividualInflammationKnowledgeLinkMalondialdehydeMapsMemoryMemory B-LymphocyteNeonatalNewborn InfantPatientsPhagocytesPhenotypePhosphorylcholinePlasma CellsPlayProcessPropertyProteinsReactionRegulationResearchRoleSerumSourceSpecificitySpleenSystemic Lupus ErythematosusThymus GlandTissuesadductchemical groupcytokineearly childhoodenzyme linked immunospot assayexperimental studyhigh dimensionalityin vivomacromoleculenatural antibodiesneonateoxidationoxidized low density lipoproteinpathogenpathogenic bacteriapathogenic viruspreventsingle-cell RNA sequencingtranscriptomeuptake
项目摘要
Project Summary
Serum IgM have crucial “housekeeping” functions such as the clearance of apoptotic cells and cellular debris,
preventing their accumulation in tissue. However, despite their important role, IgM have been largely
understudied in comparison to other immunoglobulin isotypes, especially IgG. A central characteristic of serum
IgM linked to their biological function is their reactivity to simple chemical moieties exposed on cell membranes
and macromolecules. For instance, IgM bind to phosphorylcholine on apoptotic cells to promote their elimination.
These moieties form adducts when attached to proteins or other macromolecules. Remarkably, only a few
chemical adducts recognized by serum IgM have been identified thus far. Whether these are examples of a
much larger group of chemical radicals targeted by serum IgM is unknown. To address this knowledge gap, we
developed a high-dimensional platform to assess monoclonal IgM and serum IgM reactivity to 87 ubiquitous
adducts. Results showed that: 1) monoclonal “polyreactive” IgM cloned from memory blood B cells and binding
to apoptotic cells, hence displaying a typical “natural antibody” profile, react in fact to specific adducts; 2) the
anti-adduct IgM repertoire is highly restricted in newborns and only includes reactivity to a limited number of
adducts; 3) IgM reactivity diversifies abruptly around 6 months of age, marking a transition from a restricted
neonatal repertoire to a broad adult repertoire and 4) this transition appears to coincide with exposure to
environmental antigens. Overall, these studies uncovered a much more complex anti-adduct IgM immunity than
was initially anticipated. Yet, several important questions remain unanswered: What are the functional niches of
anti-adduct B cells/PC? Do anti-adduct B cells constitute a distinct subset with specific phenotypic
characteristics? What is the role of anti-adduct IgM in efferocytosis and regulation of inflammation? Are these
functions dependent on the IgM specificity to individual adducts? Our proposed studies will address these salient
questions through the characterization of anti-adduct B cell and PC at the single-cell level.
Specific aim-1. To characterize anti-adduct memory B cells and plasma cells and map their niches
We will first detect anti-adduct memory IgM+ B cells and IgM-secreting cells in the bone marrow, spleen, thymus
and gut-associated lymphoid tissue in order to identify their main niches. We will then characterize the phenotype
of anti-adduct memory IgM+ B cells using flow cytometry and single-cell-RNA-seq combined with BCR-seq to
profile their transcriptome and evaluate their clonal composition in vivo.
Specific aim-2. To determine the role of anti-adduct IgM in regulation of efferocytosis and inflammation
In specific aim 2 we will examine the capacity of IgM mab specific to individual adducts to opsonize apoptotic
cells and enhance their clearance by different types of phagocytes. We will also investigate the role of
complement in this function. In a second part, we will examine whether apoptotic cells opsonized by IgM reactive
to different adducts trigger distinct cytokine secretion upon their uptake by phagocytes.
项目摘要
血清IgM具有至关重要的“管家”功能,例如凋亡细胞的清除和细胞碎片,
防止它们在组织中的积累。但是,涂料它们的重要作用,IgM在很大程度上是
与其他免疫球蛋白同种型,尤其是IgG相比,对研究进行了研究。系列的中心特征
与其生物学功能相关的IgM是它们对暴露在细胞膜上的简单化学部分的反应性
和大分子。例如,IgM与凋亡细胞上的磷酸胆碱结合以促进其进化。
这些部分在蛋白质或其他大分子附着时形成加合物。值得注意的是,只有少数
到目前为止,已经确定了血清IgM识别的化学加合物。这些是否是
由血清IgM靶向的更大的化学自由基尚不清楚。为了解决这个知识差距,我们
开发了一个高维平台,以评估单克隆IgM和血清IgM对87无处不在的反应性
加合物。结果表明:1)单克隆“多反应” IgM从记忆血液B细胞克隆并结合
对于凋亡细胞,因此显示出典型的“天然抗体”曲线,实际上对特定的加合物有反应。 2)
抗媒介IgM曲目在新生儿受到很高的限制,仅包括对有限数量的反应性
加合物; 3)IgM反应性在6个月大左右突然多样化,这标志着限制的过渡
新生儿曲目遍布广泛的成人曲目,4)这种过渡似乎与暴露
环境抗原。总体而言,这些研究发现了比相比
最初是预料的。但是,几个重要的问题仍未得到解决:
抗adduct B细胞/PC? DO抗adduct B细胞构成具有特定表型的独特子集
特征?抗添加剂IgM在炎症的肿瘤和调节中的作用是什么?是这些
函数取决于IGM对单个addcts的特异性?我们提出的研究将解决这些显着性
通过在单细胞水平上表征抗adduct B细胞和PC的问题。
特定的目标1。为了表征抗添加物记忆B细胞和浆细胞并绘制其壁ni
我们将首先检测到抗胶合记忆IgM+ B细胞和骨髓中的IgM分泌细胞,Sleen,胸腺
和肠道相关的淋巴组织,以鉴定其主要壁ni。然后,我们将表征表型
使用流式细胞术和单细胞-RNA-Seq与BCR-Seq结合到TO的抗添加记忆IgM+ B细胞
介绍其转录组并在体内评估其克隆组成。
特定的目标-2。确定抗添加IgM在调节肿瘤和炎症调节中的作用
在特定目标2中,我们将检查特定于个体加合物的IgM MAB的能力
细胞并通过不同类型的吞噬细胞增强清除率。我们还将调查
补充此功能。在第二部分中,我们将检查凋亡细胞是否通过IgM反应性调子
在吞噬细胞摄取时,对不同的加合物引发了不同的细胞因子秘密。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
ABO Antibody Development, a New Look at a Very Old Question.
ABO 抗体开发,一个非常古老的问题的新视角。
- DOI:10.1097/tp.0000000000004659
- 发表时间:2023
- 期刊:
- 影响因子:6.2
- 作者:Zorn,Emmanuel
- 通讯作者:Zorn,Emmanuel
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Emmanuel Zorn其他文献
Emmanuel Zorn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Emmanuel Zorn', 18)}}的其他基金
Thymic plasma cells as a source of protective natural antibodies in human neonates
胸腺浆细胞作为人类新生儿保护性天然抗体的来源
- 批准号:
10605000 - 财政年份:2022
- 资助金额:
$ 24.68万 - 项目类别:
Local antibody responses in human cardiac allograft vasculopathy
人心脏同种异体移植血管病中的局部抗体反应
- 批准号:
10457560 - 财政年份:2021
- 资助金额:
$ 24.68万 - 项目类别:
Development and significance of the plasma cell niche in the human infant thymus
人类婴儿胸腺浆细胞生态位的发育和意义
- 批准号:
10265678 - 财政年份:2020
- 资助金额:
$ 24.68万 - 项目类别:
Development and significance of the plasma cell niche in the human infant thymus
人类婴儿胸腺浆细胞生态位的发育和意义
- 批准号:
9323622 - 财政年份:2017
- 资助金额:
$ 24.68万 - 项目类别:
Development and significance of the plasma cell niche in the human infant thymus
人类婴儿胸腺浆细胞生态位的发育和意义
- 批准号:
10204980 - 财政年份:2017
- 资助金额:
$ 24.68万 - 项目类别:
Innate B cell immunity and antibody-mediated rejection of human kidney allografts
先天 B 细胞免疫和抗体介导的人肾同种异体移植排斥
- 批准号:
9239152 - 财政年份:2016
- 资助金额:
$ 24.68万 - 项目类别:
Innate B cell immunity and antibody-mediated rejection of human kidney allografts
先天 B 细胞免疫和抗体介导的人肾同种异体移植排斥
- 批准号:
9766181 - 财政年份:2016
- 资助金额:
$ 24.68万 - 项目类别:
Contribution of B cells to human cardiac allograft vasculopathy
B 细胞对人心脏同种异体移植血管病的影响
- 批准号:
9411075 - 财政年份:2015
- 资助金额:
$ 24.68万 - 项目类别:
Contribution of B cells to human cardiac allograft vasculopathy
B 细胞对人心脏同种异体移植血管病的作用
- 批准号:
9114457 - 财政年份:2015
- 资助金额:
$ 24.68万 - 项目类别:
The human innate B cell niche and role in efferocytosis
人类先天 B 细胞生态位及其在胞吞作用中的作用
- 批准号:
8875362 - 财政年份:2014
- 资助金额:
$ 24.68万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别:
Dynamic modeling of antagonism between enteric infection and undernutritionin infancy
婴儿期肠道感染与营养不良拮抗的动态模型
- 批准号:
10767667 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别:
The role of ALK4 signaling in skeletal homeostasis and pathogenesis
ALK4 信号传导在骨骼稳态和发病机制中的作用
- 批准号:
10607071 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别:
Adult epigenetics and telomere length in relation to improved nutrition in early life
成人表观遗传学和端粒长度与改善早期营养有关
- 批准号:
10562425 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别:
Molecular genetics of human age-related hearing loss
人类年龄相关性听力损失的分子遗传学
- 批准号:
10637870 - 财政年份:2023
- 资助金额:
$ 24.68万 - 项目类别: